These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 31879364)
1. PIN1 Inhibition Sensitizes Chemotherapy in Gastric Cancer Cells by Targeting Stem Cell-like Traits and Multiple Biomarkers. Zhang ZZ; Yu WX; Zheng M; Liao XH; Wang JC; Yang DY; Lu WX; Wang L; Zhang S; Liu HK; Zhou XZ; Lu KP Mol Cancer Ther; 2020 Mar; 19(3):906-919. PubMed ID: 31879364 [TBL] [Abstract][Full Text] [Related]
2. Pin1 inhibition potently suppresses gastric cancer growth and blocks PI3K/AKT and Wnt/β-catenin oncogenic pathways. Zhang Z; Yu W; Zheng M; Liao X; Wang J; Yang D; Lu W; Wang L; Zhang S; Liu H; Zhou XZ; Lu KP Mol Carcinog; 2019 Aug; 58(8):1450-1464. PubMed ID: 31026381 [TBL] [Abstract][Full Text] [Related]
3. Pin1 inhibition reverses the acquired resistance of human hepatocellular carcinoma cells to Regorafenib via the Gli1/Snail/E-cadherin pathway. Wang J; Zhang N; Han Q; Lu W; Wang L; Yang D; Zheng M; Zhang Z; Liu H; Lee TH; Zhou XZ; Lu KP Cancer Lett; 2019 Mar; 444():82-93. PubMed ID: 30583078 [TBL] [Abstract][Full Text] [Related]
4. Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells. Chen DH; Yu JW; Wu JG; Wang SL; Jiang BJ J Cancer Res Clin Oncol; 2015 Dec; 141(12):2109-20. PubMed ID: 25952582 [TBL] [Abstract][Full Text] [Related]
5. Roles of Pin1 as a Key Molecule for EMT Induction by Activation of STAT3 and NF-κB in Human Gallbladder Cancer. Nakada S; Kuboki S; Nojima H; Yoshitomi H; Furukawa K; Takayashiki T; Takano S; Miyazaki M; Ohtsuka M Ann Surg Oncol; 2019 Mar; 26(3):907-917. PubMed ID: 30610554 [TBL] [Abstract][Full Text] [Related]
6. The promotion of the transformation of quiescent gastric cancer stem cells by IL-17 and the underlying mechanisms. Jiang YX; Yang SW; Li PA; Luo X; Li ZY; Hao YX; Yu PW Oncogene; 2017 Mar; 36(9):1256-1264. PubMed ID: 27524415 [TBL] [Abstract][Full Text] [Related]
7. Isolation and identification of chemotherapy-enriched sphere-forming cells from a patient with gastric cancer. Bagheri V; Memar B; Behzadi R; Aliakbarian M; Jangjoo A; Bahar MM; Talebi S; Gholamin M; Abbaszadegan MR J Cell Physiol; 2018 Oct; 233(10):7036-7046. PubMed ID: 29744869 [TBL] [Abstract][Full Text] [Related]
8. RETRACTED: CD44 expression denotes a subpopulation of gastric cancer cells in which Hedgehog signaling promotes chemotherapy resistance. Yoon C; Park DJ; Schmidt B; Thomas NJ; Lee HJ; Kim TS; Janjigian YY; Cohen DJ; Yoon SS Clin Cancer Res; 2014 Aug; 20(15):3974-88. PubMed ID: 24947926 [TBL] [Abstract][Full Text] [Related]
9. Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways. Lian X; Lin YM; Kozono S; Herbert MK; Li X; Yuan X; Guo J; Guo Y; Tang M; Lin J; Huang Y; Wang B; Qiu C; Tsai CY; Xie J; Gao ZJ; Wu Y; Liu H; Zhou XZ; Lu KP; Chen Y J Hematol Oncol; 2018 May; 11(1):73. PubMed ID: 29848341 [TBL] [Abstract][Full Text] [Related]
10. miR-98-5p inhibits gastric cancer cell stemness and chemoresistance by targeting branched-chain aminotransferases 1. Zhan P; Shu X; Chen M; Sun L; Yu L; Liu J; Sun L; Yang Z; Ran Y Life Sci; 2021 Jul; 276():119405. PubMed ID: 33798550 [TBL] [Abstract][Full Text] [Related]
11. Prolyl isomerase Pin1 acts downstream of miR200c to promote cancer stem-like cell traits in breast cancer. Luo ML; Gong C; Chen CH; Lee DY; Hu H; Huang P; Yao Y; Guo W; Reinhardt F; Wulf G; Lieberman J; Zhou XZ; Song E; Lu KP Cancer Res; 2014 Jul; 74(13):3603-16. PubMed ID: 24786790 [TBL] [Abstract][Full Text] [Related]
12. Targeting PIN1 exerts potent antitumor activity in pancreatic ductal carcinoma via inhibiting tumor metastasis. Chen L; Xu X; Wen X; Xu S; Wang L; Lu W; Jiang M; Huang J; Yang D; Wang J; Zheng M; Zhou XZ; Lu KP; Liu H Cancer Sci; 2019 Aug; 110(8):2442-2455. PubMed ID: 31148345 [TBL] [Abstract][Full Text] [Related]
13. Construction and application of a lung cancer stem cell model: antitumor drug screening and molecular mechanism of the inhibitory effects of sanguinarine. Yang J; Fang Z; Wu J; Yin X; Fang Y; Zhao F; Zhu S; Li Y Tumour Biol; 2016 Oct; 37(10):13871-13883. PubMed ID: 27485114 [TBL] [Abstract][Full Text] [Related]
14. All-Trans Retinoic Acid and Doxorubicin Delivery by Folic Acid Modified Polymeric Micelles for the Modulation of Pin1-Mediated DOX-Induced Breast Cancer Stemness and Metastasis. Liu Y; Yu F; Dai S; Meng T; Zhu Y; Qiu G; Wen L; Zhou X; Yuan H; Hu F Mol Pharm; 2021 Nov; 18(11):3966-3978. PubMed ID: 34579532 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of the prolyl isomerase Pin1 enhances the ability of sorafenib to induce cell death and inhibit tumor growth in hepatocellular carcinoma. Zheng M; Xu H; Liao XH; Chen CP; Zhang AL; Lu W; Wang L; Yang D; Wang J; Liu H; Zhou XZ; Lu KP Oncotarget; 2017 May; 8(18):29771-29784. PubMed ID: 28404959 [TBL] [Abstract][Full Text] [Related]
16. RETRACTED: Role of Rac1 Pathway in Epithelial-to-Mesenchymal Transition and Cancer Stem-like Cell Phenotypes in Gastric Adenocarcinoma. Yoon C; Cho SJ; Chang KK; Park DJ; Ryeom SW; Yoon SS Mol Cancer Res; 2017 Aug; 15(8):1106-1116. PubMed ID: 28461325 [TBL] [Abstract][Full Text] [Related]
18. Shrimp miRNA suppresses the stemness of human cancer stem cells Zhang S; Zhang X FASEB J; 2019 Oct; 33(10):10767-10779. PubMed ID: 31284761 [TBL] [Abstract][Full Text] [Related]
19. Alternative splice variants of DCLK1 mark cancer stem cells, promote self-renewal and drug-resistance, and can be targeted to inhibit tumorigenesis in kidney cancer. Ge Y; Weygant N; Qu D; May R; Berry WL; Yao J; Chandrakesan P; Zheng W; Zhao L; Zhao KL; Drake M; Vega KJ; Bronze MS; Tomasek JJ; An G; Houchen CW Int J Cancer; 2018 Sep; 143(5):1162-1175. PubMed ID: 29577277 [TBL] [Abstract][Full Text] [Related]
20. Impact of PIN1 Inhibition on Tumor Progression and Chemotherapy Sensitivity in Colorectal Cancer. Gholamzadeh Khoei S; Saidijam M; Amini R; Jalali A; Najafi R J Gastrointest Cancer; 2022 Jun; 53(2):299-310. PubMed ID: 33580870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]